Stents

Cath Lab

Stents

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

Abbott announced CE mark in Europe for the Xience Xpedition 48 Everolimus Eluting Coronary Stent System, the first-of-its-kind treatment for very long blockages in the vessels that supply blood to the heart due to coronary artery disease (CAD)....

University of Maryland Medical Center Launches Genetic-Testing Program For Cardiac Stent Patients

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on information found in their genes. As part of a new personalized medicine initiative, the med...

Elixer bioresorbable stent
Elixir Gains European Approval for Fully Bioresorbable Drug-Eluting Coronary Stent

Elixir Medical Corp. announced it received CE (Conformité Européenne) mark approval for its DESolve Novolimus-eluting bioresorbable coronary stent scaffold system. The scaffold is designed to degrade in about one year returning the...

Zilver PTX Drug Eluting Stent Recalled Due to Catheter Separation Issue

Cook Medical has initiated a global voluntary recall of its Zilver PTX Drug Eluting Peripheral Stent based on its investigation into a small number of complaints that the delivery system of the device had separated at the tip of the inner catheter...

Tryton Side Branch Stent Nordic-Baltic Bifurcation Study Group Clinical Trial
Tryton Announces Nordic-Baltic Dedicated Bifurcation Trial...
Tryton Medical Inc. announced that the Nordic-Baltic Bifurcation Study Group will investigate the Tryton Side Branch Stent. The trial is a prospective,...
Axxess Self-Expanding Bifurcation DES Safe, Effective up to...
New long-term data from the DIVERGE study, presented at EuroPCR 2013 by Principal Investigator Dr. Stefan Verheye, Antwerp Cardiovascular Centre, ZNA...
OrbusNeich Receives CE Mark for Combo Dual-Therapy Stent
June 3, 2013 — OrbusNeich has launched the world's first dual-therapy stent to address the challenges of delayed healing of the coronary artery associated with...
Xience Xpedition 48 Abbott Vascular CE mark Europe
Abbott Announces CE Mark for World's Longest Coronary...
Abbott announced CE mark in Europe for the Xience Xpedition 48 Everolimus Eluting Coronary Stent System, the first-of-its-kind treatment for very long...
Medtronic Resolute Integrity Stent FDA Approval 34, 38 mm
New Sizes of Medtronic Resolute Integrity Target Long Coronary Lesions
The 34 and 38 mm lengths of the Medtronic Resolute Integrity drug-eluting stent in diameters of 3, 3.5 and 4 mm with an indication for
S.M.A.R.T. Control Vascular Stent System for (SFA) and/or (PPA) Use
Cordis Corporation's  S.M.A.R.T. Control Vascular Stent Systems are designed for use in the superficial femoral artery (SFA) and/or...
Zilver PTX is First Drug-Eluting Peripheral Stent
Cook Medical’s Zilver PTX drug-eluting peripheral stent is the first device of its kind on several fronts to go before FDA review...
View All »

Articles

mGuard stent, STEMI
InspireMD's MGuard Embolic Protection Stent Shows...
InspireMD Inc. announced new six-month results from the MASTER trial demonstrating that the MGuard embolic protection stent (EPS) outperformed bare metal...
University of Maryland Medical Center Genetic-Testing Program Cardiac Stent
University of Maryland Medical Center Launches Genetic-...
Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on...
Elixer bioresorbable stent
Elixir Gains European Approval for Fully Bioresorbable Drug...
Elixir Medical Corp. announced it received CE (Conformité Européenne) mark approval for its DESolve Novolimus-eluting bioresorbable coronary stent...
bioresorbable stent, zinc stent
Zinc Bioresorbable Stents May Offer Alternative to...
University of Michigan researchers said the preliminary results of using biresorbable zinc stents were amazing, with corrosion rates exactly where they need to...

Video Center

view all Videos »

New Trends and Technology in Electrophysiology from HRS 2013
The Heart Rhythm Society (HRS) 2013 scientific sessions covered the latest research and technology...
1 week 6 days ago
The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
15 weeks 3 hours ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
19 weeks 2 days ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...